Hamlin Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,314,277
| Closed | -$71.7M | – | 42 |
|
|
2020
Q1 | $71.7M | Buy |
2,314,277
+112,243
| +5% | +$3.48M | 4.29% | 3 |
|
|
2019
Q4 | $81.9M | Sell |
2,202,034
-4,961
| -0.2% | -$184K | 3.41% | 8 |
|
|
2019
Q3 | $75.2M | Sell |
2,206,995
-129,007
| -6% | -$4.4M | 3.38% | 11 |
|
|
2019
Q2 | $96M | Sell |
2,336,002
-29,537
| -1% | -$1.21M | 4.12% | 3 |
|
|
2019
Q1 | $95.3M | Sell |
2,365,539
-84,039
| -3% | -$3.39M | 4.25% | 5 |
|
|
2018
Q4 | $101M | Sell |
2,449,578
-342,792
| -12% | -$14.2M | 4.72% | 2 |
|
|
2018
Q3 | $117M | Sell |
2,792,370
-100,286
| -3% | -$4.19M | 4.58% | 1 |
|
|
2018
Q2 | $99.6M | Sell |
2,892,656
-86,586
| -3% | -$2.98M | 4.05% | 4 |
|
|
2018
Q1 | $100M | Buy |
2,979,242
+9,818
| +0.3% | +$331K | 3.88% | 6 |
|
|
2017
Q4 | $102M | Sell |
2,969,424
-67,861
| -2% | -$2.33M | 3.92% | 5 |
|
|
2017
Q3 | $103M | Sell |
3,037,285
-12,510
| -0.4% | -$424K | 4.17% | 6 |
|
|
2017
Q2 | $97.2M | Buy |
3,049,795
+48,786
| +2% | +$1.55M | 4.06% | 3 |
|
|
2017
Q1 | $97.4M | Buy |
3,001,009
+838,050
| +39% | +$27.2M | 4.11% | 1 |
|
|
2016
Q4 | $66.7M | Buy |
2,162,959
+459,632
| +27% | +$14.2M | 2.98% | 12 |
|
|
2016
Q3 | $54.7M | Sell |
1,703,327
-39,701
| -2% | -$1.28M | 2.53% | 24 |
|
|
2016
Q2 | $58.2M | Buy |
1,743,028
+47,117
| +3% | +$1.57M | 2.82% | 20 |
|
|
2016
Q1 | $47.7M | Buy |
+1,695,911
| New | +$47.7M | 2.41% | 29 |
|